Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT07671755

Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment

Conditions: Clinical Response, Radiological Response

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: No

Phase: NA

Enrollment: 80

Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma

Location: Shaheed Mohtarma Benazir Bhutto Institue of Trauma Karachi

Summary

This study aims to evaluate clinical outcomes of colistin versus colistin in combination with cefoperazone-sulbactam for patients with MDR-AB VAP treatment.

Eligibility Criteria

Inclusion Criteria: * Patients with a diagnosis of VAP due to A. baumannii Exclusion Criteria: * patients who had polymicrobial VAP * Patients with pre-existing severe renal failure and/or abnormal liver function tests * Patients allergic to colistin or cefoperazone-sulbactam

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07671755). StuddyBuddy aggregates publicly available trial information.